Recent Advances in Zika Virus Vaccines

被引：32

作者：

Garg, Himanshu ^{[1
]}

Mehmetoglu-Gurbuz, Tugba ^{[1
]}

Joshi, Anjali ^{[1
]}

机构：

[1] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Ctr Emphasis Infect Dis, El Paso, TX 79905 USA

来源：

VIRUSES-BASEL | 2018年 / 10卷 / 11期

关键词：

Zika virus; flaviviruses; vaccines; virus like particles; clinical trials; ZIKV; RECOMBINANT SUBVIRAL PARTICLES; NEUTRALIZING IMMUNE-RESPONSES; PROTECTIVE EFFICACY; ENCEPHALITIS-VIRUS; MESSENGER-RNA; DNA VACCINE; MICE; PROTEINS; IMMUNOGENICITY; IMMUNIZATION;

D O I：

10.3390/v10110631

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The recent outbreaks of Zika virus (ZIKV) infections and associated microcephaly in newborns has resulted in an unprecedented effort by researchers to target this virus. Significant advances have been made in developing vaccine candidates, treatment strategies and diagnostic assays in a relatively short period of time. Being a preventable disease, the first line of defense against ZIKV would be to vaccinate the highly susceptible target population, especially pregnant women. Along those lines, several vaccine candidates including purified inactivated virus (PIV), live attenuated virus (LAV), virus like particles (VLP), DNA, modified RNA, viral vectors and subunit vaccines have been in the pipeline with several advancing to clinical trials. As the primary objective of Zika vaccination is the prevention of vertical transmission of the virus to the unborn fetus, the safety and efficacy requirements for this vaccine remain unique when compared to other diseases. This review will discuss these recent advances in the field of Zika vaccine development.

引用

页数：13

共 74 条

[1] Durability and correlates of vaccine protection against Zika virus in rhesus monkeys [J].

Abbink, Peter ;

Larocca, Rafael A. ;

Visitsunthorn, Kittipos ;

Boyd, Michael ;

De la Barrera, Rafael A. ;

Gromowski, Gregory D. ;

Kirilova, Marinela ;

Peterson, Rebecca ;

Li, Zhenfeng ;

Nanayakkara, Ovini ;

Nityanandam, Ramya ;

Mercado, Noe B. ;

Borducchi, Erica N. ;

Chandrashekar, Abishek ;

Jetton, David ;

Mojta, Shanell ;

Gandhi, Priya ;

LeSuer, Jake ;

Khatiwada, Shreeya ;

Lewis, Mark G. ;

Modjarrad, Kayvon ;

Jarman, Richard G. ;

Eckels, Kenneth H. ;

Thomas, Stephen J. ;

Michael, Nelson L. ;

Barouch, Dan H. .

SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (420)

[2] Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys [J].

Abbink, Peter ;

Larocca, Rafael A. ;

De La Barrera, Rafael A. ;

Bricault, Christine A. ;

Moseley, Edward T. ;

Boyd, Michael ;

Kirilova, Marinela ;

Li, Zhenfeng ;

Ng'ang'a, David ;

Nanayakkara, Ovini ;

Nityanandam, Ramya ;

Mercado, Noe B. ;

Borducchi, Erica N. ;

Agarwal, Arshi ;

Brinkman, Amanda L. ;

Cabral, Crystal ;

Chandrashekar, Abishek ;

Giglio, Patricia B. ;

Jetton, David ;

Jimenez, Jessica ;

Lee, Benjamin C. ;

Mojta, Shanell ;

Molloy, Katherine ;

Shetty, Mayuri ;

Neubauer, George H. ;

Stephenson, Kathryn E. ;

Peron, Jean Pierre S. ;

Zanotto, Paolo M. de A. ;

Misamore, Johnathan ;

Finneyfrock, Brad ;

Lewis, Mark G. ;

Alter, Galit ;

Modjarrad, Kayvon ;

Jarman, Richard G. ;

Eckels, Kenneth H. ;

Michael, Nelson L. ;

Thomas, Stephen J. ;

Barouch, Dan H. .

SCIENCE, 2016, 353 (6304) :1129-1132

[3] Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L [J].

Anderson, Bart R. ;

Muramatsu, Hiromi ;

Jha, Babal K. ;

Silverman, Robert H. ;

Weissman, Drew ;

Kariko, Katalin .

NUCLEIC ACIDS RESEARCH, 2011, 39 (21) :9329-9338

[4]

[Anonymous], 2013, MATH PROBL ENG

[5] Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity [J].

Bardina, Susana V. ;

Bunduc, Paul ;

Tripathi, Shashank ;

Duehr, James ;

Frere, Justin J. ;

Brown, Julia A. ;

Nachbagauer, Raffael ;

Foster, Gregory A. ;

Krysztof, David ;

Tortorella, Domenico ;

Stramer, Susan L. ;

Garcia-Sastre, Adolfo ;

Krammer, Florian ;

Lim, Jean K. .

SCIENCE, 2017, 356 (6334) :175-180

[6] Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells [J].

Basu, Rupsa ;

Zhai, Lukai ;

Contreras, Alice ;

Tumban, Ebenezer .

VACCINE, 2018, 36 (10) :1256-1264

[7]

BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6

[8] Cutting Edge: Innate Immune Augmenting Vesicular Stomatitis Virus Expressing Zika Virus Proteins Confers Protective Immunity [J].

Betancourt, Dillon ;

de Queiroz, Nina M. G. P. ;

Xia, Tianli ;

Ahn, Jeonghyun ;

Barber, Glen N. .

JOURNAL OF IMMUNOLOGY, 2017, 198 (08) :3023-3028

[9] Zika virus-like particle (VLP) based vaccine [J].

Boigard, Helene ;

Alimova, Alexandra ;

Martin, George R. ;

Al Katz ;

Gottlieb, Paul ;

Galarza, Jose M. .

PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (05)

[10] An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+T cell responses in a mouse model [J].

Chahal, Jasdave S. ;

Fang, Tao ;

Woodham, Andrew W. ;

Khan, Omar F. ;

Ling, Jingjing ;

Anderson, Daniel G. ;

Ploegh, Hidde L. .

SCIENTIFIC REPORTS, 2017, 7

← 1 2 3 4 5 6 7 8 →